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Since the molecular identification of the capsaicin receptor, now known as TRPV1, transient receptor potential (TRP) channels have occupied
an important place in the understanding of sensory nerve function in the context of pain. Several TRP channels exhibit sensitivity to substances
previously known to cause pain or pain-like sensations; these include cinnamaldehyde, menthol, gingerol, and icillin. Many TRP channels also
exhibit significant sensitivity to increases or decreases in temperature. Some TRP channels are sensitized in vitro by the activation of other
receptors such that these channels may be activated by processes, such as inflammation that result in pain. TRP channels are suggested to be
involved in processes as diverse as sensory neuron activation events, neurotransmitter release and action in the spinal cord, and release of
inflammatory mediators. These functions strongly suggest that specific and selective inhibition of TRP channel activity will be of use in alleviating
pain.
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In the past few decades a tremendous amount of research has
been performed in an attempt to elucidate and understand the
factors and mechanisms involved in normal sensory and pain
perception. Preclinical research has uncovered a multitude of
factors, pathways and mechanisms that are involved in the
development and maintenance of pathological pain-like sensory
sensitivity in animal models. Key discoveries in the pain field
include the description of injury-induced alteration of neuronal
function [1], the discovery of changes in peripheral neuron
functioning and in neuronal processing within the spinal cord
[2,3], the development of animal models of neuropathic pain
[4–7], and the role of immune and glial cells in the development
of pain [8–10]. These discoveries have generated optimism that
new therapeutic regimens may be forthcoming to alleviate
abnormally heightened and spontaneous pain.
However, despite these advances the translation of this
preclinical research to the treatment of pain has been slow to
occur. This is partly due to the lack of understanding of the⁎ Corresponding author.
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key to animal research models. This is evident by the relative
paucity of mechanistically novel therapeutic agents that have
entered into the clinic for the treatment of pain in recent years.
Although the use of new agents for pain has risen (for example,
gabapentin and the COX-2 inhibitors), the mainstay of therapy
remains agents such as opiates and non-steroidal anti-inflam-
matory drugs (NSAID) that have been around for a number of
years, even centuries. Of the newer agents, the COX-2
inhibitors provided an extremely promising line of therapy for
inflammatory conditions before side-effects cast a shadow over
the use of the class as a whole. NEURONTIN (gabapentin) has
offered insight into a potentially new mechanism, the α2δ
calcium channel [11]. Furthermore, although Neurontin is one
of the most prescribed pain relief medications for neuropathic
conditions, there is still room for improvement. In clinical trials
of post-herpetic and trigeminal neuralgia the number-needed-to-
treat (NNT) was approximately 3–4 [12]. A more potent
successor to gabapentin, pregabalin (LYRICA), has recently
reached the market. It appears to improve on the potency of
gabapentin and may provide further clinical validation for the
α2δ mechanism. Finally, ziconotide (PRIALT), a conopeptide
N-type calcium channel blocker also has beneficial use in
979D.N. Cortright et al. / Biochimica et Biophysica Acta 1772 (2007) 978–988treating pain, yet side effects and its route of administration
(intrathecal delivery) limit its use to opiate-refractory, severe
chronic pain. In summary, clinical therapy for pain relies on
agents that do not provide adequate relief in a large number of
patients to whom they are prescribed and, therefore, can be
significantly improved upon [13]. There remains a great need
for new therapeutic agents acting via novel mechanisms in this
field of medicine.
A recent development in the search for novel analgesics is the
advance into clinical testing of small molecule antagonists of the
TRPV1 channel [14]. TRPV1 is amember of the TRP ion channel
family and is the receptor for capsaicin [15]. TRPV1 has been
shown to be an extremely promising target for the development of
novel analgesic therapeutics and beckons examination of other,Fig. 1. Timeline of research milestones in study of TRP channels in pain. TRPV1 h
research milestones in the area are biased toward TRPV1 (right side of timeline). No
with two TRPV1 antagonists. Other research milestones are centered on the discove
functions in immune cells (left side of timeline). The role of TRPM8 in pain is unclea
sensory channel. ROS is reactive oxygen species. TRPV1 milestone references arerelevant members of this class of channels. Indeed, in the years
that have followed the cloning of TRPV1, additional TRP family
members have been identified (Fig. 1), which are expressed in
sensory fibers, and which are implicated in sensory processing,
including TRPV2, TRPV3, TRPV4, TRPA1 and TRPM8 [16].
These and other TRP channel members may hold promise as
relevant targets for the discovery of the next generation of
analgesic agents.
2. Algogenic natural substances and TRP channels
Perhaps the most exciting insight into the molecular nature of
pain in the last 10 years has been the identification of proteins
that serve as functional receptors for chemicals known to causeas been the most studied of the TRP channels with respect to pain, and, thus,
te that 10 years after the description of capsazepine, Phase 1 trials were initiated
ry of other TRP family channels with sensory transduction capabilities or with
r, but its discovery was the first description of a cool/cold temperature-sensitive
[131,132,15,53,133,41,42,136], and [134].
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tremendous tools with which to identify and characterize these
receptors (reviewed by [17]). The first to be identified was
TRPV1 as the receptor for capsaicin and related vanilloids [15].
TRPV1 is also the receptor for other algogenic substances or
irritants, including resiniferatoxin, a vanilloid [15,18], piperine,
the primary irritant in black pepper [19], gingerol [20], and
eugenol, a component of clove oil [21]. Venoms from cnidarians,
such as jellyfish, and the spiders Psalmopoeus cambridgei and
Ornithoctunus huwena are also activators of TRPV1 [22,23].
The TRPA1 channel is also activated by gingerol and eugenol,
but more importantly is the receptor for mustard oil [24,25]. The
effects of mustard oil on TRPA1 appear to be mediated largely
through allyl isothiocyanates which activate the channel via
reversible, covalent modification of cysteine residues [26,27].
Cinnamaldehyde, which is found in cinnamon oil and is the most
specific TRPA1 ligand [24], also activates TRPA1 via covalent
modification [27]. TRPA1 is also activated by extracts of other
isothiocyanate-containing plants, including horseradish, and
garlic, which contains a thiosulfinate [24,25,28,29]. It is also
activated by wintergreen oil [24]. Curiously, delta(9)-tetrahy-
drocannabinol (THC), a psychoactive ingredient in marijuana,
which is known to mediate analgesia, is also a reported activator
of TRPA1 [25].
Several TRP channels are also activated by natural
substances which are associated with certain sensory and/or
medicinal effects, but not necessarily pain. TRPM8 has been
termed the ‘minty-cool’ receptor [30], a reflection of its role as a
receptor for menthol and eucalyptol and other selected
monoterpenes [31–33]. TRPV3 is also activated by natural
products, including carvacrol (from oregano), thymol (from
thyme), eugenol, and camphor [34,35]. Interestingly, vanillin,
the primary flavoring component of vanilla bean extract, and
ethyl-vanillin appear to be the most effective of the TRPV3
natural product activators described to date [34]. Finally, a
compound called bisandrographolide A, which is found in
extracts of the Chinese medicinal plant Andrographis panicu-
lata, is an activator of TRPV4 [36].
Many of these ligands exhibit promiscuous binding to TRP
channels. For example, eugenol activates TRPV1, TRPA1,
TRPM8 and TRPV3 [21,24,34], and carvacrol activates TRPV3
and TRPA1 [34]. In contrast, MacPherson and coworkers [37]
have shown that menthol activates TRPM8 and TRPV3, but
inhibits TRPA1. Conversely, cinnamaldehyde activates TRPA1,
but high concentrations inhibit TRPM8 [37]. Capsaicin, it
would seem, is the only selective ligand of the lot. Thus, while it
is clear that TRP channels are important mediators of natural
products' effects, our understanding of the contribution of
specific channels to a particular compound's pharmacological
effects is still emerging.
3. TRP channels as coincident sensors of temperature and
phospholipid metabolism: implications for nociceptive
processing
Certain TRP channels, particularly channels expressed in
skin and sensory neurons (DRG), exhibit exquisite sensitivity tochanges in temperature. Indeed, the thermal sensitivities of
TRPV2 and TRPV3 were a defining feature of their activation
when first molecularly characterized. Of particular interest has
been the finding that each thermally sensitive TRP channel
(“thermo TRP”) exhibits a unique activation threshold in vitro;
for example, TRPV1 is activated at temperatures of ∼43 °C,
TRPA1 at ∼17 °C, and TRPV4 at 27 °C, TRPV3 at 33 °C,
TRPM8 at 26 °C, and TRPV2 at>50 °C (reviewed in [38–40]).
Since these thermoTRPs exhibit unique, albeit overlapping
distributions within sensory nerve fibers, it is plausible that
thermoTRPs mediate unique cellular responses of sensory
neurons to temperature change. In fact, genetic deletion of
TRPV1 [41,42], TRPV3 [35], or, in some studies, TRPA1 [44]
results in alterations in sensitivity to warm/hot (TRPV1,
TRPV3) or cold temperatures (TRPA1). In addition to their
function as peripheral temperature sensors, an emerging
literature indicates that TRP channels participate in aspects of
thermoregulation [45].
The ability to detect cold or hot temperatures, particularly at
noxious temperatures (below 17 °C or above 43 °C), has
suggested a role for channels such as TRPA1, TRPV1, and
TRPV2 in sensing painful temperature conditions, roles that to
this point have been corroborated by additional studies
(described in detail below). Interestingly, TRPV3−/− mice do
not develop thermal hyperalgesia in response to inflammation
[35], even though TRPV3 exhibits increased current responses
to repeated heat stimulation [45]. Thus, thermal sensitivity per
se is not sufficient to drive nociception.
A number of TRP channels have been shown to be activated
by phospholipid signaling molecules such as diacylglycerol
(DAG). Activation of phospholipid metabolism is an important
downstream event mediated by G protein-coupled receptors
linked to nociceptive signaling, such as bradykinin and
prostaglandins. TRPA1, TRPV3, and TRPV4 are all activated
by increased phospholipase C (PLC) activity [24,34,46], and
TRPV1, which is negatively regulated by phosphatidylinositol
bis-phosphate (PIP2), is sensitized by increased PLC activity
[47]. TRPV4 and TRPM8 are activated by the products of
phospholipase A2 activity [48,49], whereas PLC activation
desensitizes TRPM8 activity [50]. In some cases, lipid
metabolites are direct activators of these channels, as exempli-
fied by the activation of TRPV1 by anandamide, 12-hydro-
peroxyeicosatetraenoic acid (12-HEPTE), and N-acyl taurines
[51,52], and the activation of TRPM8 by lysophospholipids
[49].
Perhaps the most intriguing aspect of heat and phospholipid
sensitivity of TRP channels relates to their ability to integrate
multiple stimuli. Tominaga and coworkers [53] provided the
first evidence of integration with the demonstration that the
temperature activation threshold for TRPV1 could be shifted to
cooler temperatures by low pH solutions (pH 6.4 vs. pH 7.4).
This was followed by the demonstration that increased
phosphorylation of TRPV1 via protein kinase C could also
sensitize the channel to heat [54,55]. Finally, mildly low pH
(6.8) in combination with a moderate increase in PKC activity
can result in activation of TRPV1 current responses at 37 °C
[56], thus, demonstrating the ability of TRPV1 to activate a
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release of pro-inflammatory mediators, increased local blood
flow and temperature) that might be found during inflammatory
pain processes. Other data support multimodal integration roles
for TRPA1 [57], TRPV4 [46,58], and TRPM8 [49].
4. In vivo evidence for the importance of TRP channels
in pain
In view of the emerging molecular pharmacology of TRP
channels expressed in sensory neurons, particularly those
channels which mediate the effects of well known algogenic
substances, it is not surprising that significant attention has been
focused on the role these channels in pain. Numerous small
molecule TRPV1 antagonists have been reported which further
support its central role in pain. Genetic knockdown and
knockout strategies have been deployed to study TRPV1,
TRPA1, TRPV4, and TRPM8.
4.1. TRPV1
TRPV1 has been the subject of intense study and academic
review [14,18,51,59–61]. In brief, TRPV1 is highly expressed
in a subset of sensory neurons fibers generally referred to as
nociceptors. This site of expression is consistent with the ability
of TRPV1 agonists, like capsaicin, to trigger nociception in
animals. Activation of TRPV1 in sensory fibers also releases
neuropeptides such as substance P and calcitonin gene-related
peptide causing increased blood flow and edema, sometimes
referred to as neurogenic inflammation [18]. Perhaps the most
outstanding feature of TRPV1 is, as noted above, its ability to
integrate the effects of multiple noxious stimuli and inflamma-
tory mediators, a characteristic which combined with TRPV1's
cellular localization provides an intriguing rationale for the
utility of TRPV1 antagonists in the treatment of pain.
In fact, numerous TRPV1 antagonists have been reported
which exhibit efficacy in a wide range of pre-clinical pain
models [14, 51]. These reports corroborate to a significant
extent the phenotypes of TRPV1−/− mice in experimental pain,
and are in agreement with the effects of TRPV1 knockdown via
anti-sense oligonucleotide or RNA interference [62,63]. Several
TRPV1 antagonists are currently in Phase II clinical trials for
pain (SB-705498 and MK2295/NGD 8243) so a first look at
TRPV1 as a mechanistic target for pain should be forthcoming
shortly.
4.2. TRPA1
TRPA1 is expressed mostly in subsets of small DRG neurons
and has been considered to be a noxious cold-sensing channel as
it is activated by temperatures lower than 17 °C, lower than that
of TRPM8, the “minty-cool” or menthol receptor [30,40]. It is
also activated by bradykinin in a bradykinin receptor-dependent
manner and may potentially function as a signal integrator much
like TRPV1 [24]. TRPA1 expression is not limited to DRG
neurons, as it is expressed on hair cell stereocilia, thus, implying
a role in hearing. In fact, antisense experiments providedsupport for a role of TRPA1 in hearing [64], but TRPA1
knockout mice do not display deficits in auditory responses
[43,44].
Antisense and knockout studies have identified a role for
TRPA1 in pain mechanisms. TRPA1 expression is induced
following both inflammatory and nerve injuries and antisense
knockdown of the channel resulted in decreased cold
hyperalgesia with little effect on thermal (heat) hyperalgesia
or mechanical allodynia resulting from these conditions [65].
More recent genetic TRPA1 knockout studies have identified a
loss of mustard oil- and bradykinin-induced hypersensitivity in
knockout animals with no effect seen on CFA-induced thermal
hypersensitivity or spared nerve injury-induced mechanical
allodynia [43,44]. Interestingly, although data has implicated
TRPA1 in cold sensing, data from knockout mice in this regard
are mixed and further studies have failed to correlate this
channel with cold sensing neurons [25]. Therefore, the role of
TRPA1 in normal cold sensing remains controversial and
further research is needed to elucidate its physiological function
in temperature sensing. However, reports have suggested that
post-injury, TRPA1 plays a role in cold hypersensitivity [65,66]
indicating that TRPA1 may be a potentially attractive target for
pathophysiological cold pain.
4.3. TRPM8
TRPM8 is a temperature- and ligand-gated channel that is
activated by temperatures in a modestly cool range, activating at
approximately 26 °C and saturating at approximately 8 °C. This
activation range overlaps with TRPA1, but extends to warmer
temperatures [31]. Despite the cool temperature sensitivity of
TRPM8, antisense oligonucleotides directed against TRPM8
conferred no alteration in nerve injury-induced cold hypersen-
sitivity [66]. On the other hand, activation of TRPM8 has been
demonstrated to produce analgesia, an effect that is lost with
TRPM8 antisense oligonucleotide treatment [67]. These
experiments suggest a role for TRPM8 as a cold analgesia
transduction mechanism therefore accounting for the cooling
analgesia for which menthol has long been employed.
4.4. TRPV4
TRPV4 is a channel that can be heat- and ligand-activated
similar to other TRP channels. Ligands that can activate this
channel include phorbol derivatives [68] and endocannabinoid/
arachidonic acid metabolites (5′,6′-EET; [48]). Temperature
activation is in a warm range (greater than 27 °C) lower than
that required to activate TRPV1 [69,70]. Interestingly, it can
also be activated by osmolarity and low pH and may serve as an
integrator between mechanosensation and osmoregulation
[71,72]. Consistent with a role in osmoregulation, TRPV4 is
expressed in the kidney and in circumventricular organs in the
CNS [72–74]. TRPV4 is also expressed in dorsal root ganglia,
trigeminal ganglia, and mechanosensory terminals in the skin as
well as cochlear hair cells and vibrissal Merkel cells indicating a
potential role in mechanosensation. Indeed, studies have
identified a function for TRPV4 in normal hearing [71,74–76].
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TRPV4 in acid and mechanical sensing while these animals
displayed normal heat and touch sensation [77,78]. Further
studies have demonstrated a role for TRPV4 in thermal sensing
under inflammatory conditions [79] and in environmental
temperature sensation [80] consistent with channel activation
by heat. Therefore, although its role in normal, uninjured
physiology is unclear, TRPV4 appears to be an important player
in pathological sensory perception. A further intriguing finding
indicates a potentially key role of TRPV4 in chemotherapy-
induced neuropathy. In a study by Alessandri-Haber and
colleagues [81], antisense treatment targeting TRPV4 comple-
tely reversed Taxol-induced mechanical hypersensitivity. As
chemotherapy-induced neuropathy is a common, potentially
irreversible side effect caused by some chemotherapeutic agents
[82], these data suggest a potential mechanism to combat this
side effect. Further studies with both knockout animals and
antisense administration have demonstrated a role for TRPV4 in
inflammatory pain, but not in normal pain sensing [58].
However, a potential role in central osmoregulation may limit
the therapeutic benefit of targeting TRPV4 [83].
5. Emerging functions of TRP channels and implications
for pain
From the perspective of pain research, much of the focus in
the TRP channel field has been on the functional activity of
channels expressed in sensory neurons. Mechanistically, thisFig. 2. Cartoon illustration of cell types important in the generation and/or sensory
expressed in dorsal root ganglion neurons that exhibit sensory projections to periph
projections to the spinal cord (efferents). The circle overlay on the spinal column illu
dorsal areas. Certain cell types in peripheral tissues may be involved in the transduc
channels; for example, TRPV3 and TRPV4 are expressed in keratinocytes [15] and TR
channels are found in both sensory fiber ends as well as in certain cell bodies. TR
participate in the release of mediators that activate nociception. TRP channels are also
pain [8–10]. However, the functional contribution, if any, of TRP channels to microfocus has largely been on TRP channels as temperature sensors
and mediators of natural substance effects. However, other TRP
channel functions have been described, including the early
description of TRP channels as mediators of calcium release-
activated currents (see below). In addition, TRP channels are
found in cells of the central nervous system and in diverse, non-
neuronal cell types all of which participate in generation,
sensing, and processing of pain signals (Fig. 2).
5.1. TRP channels and mechanical pain
One of the unanswered questions involved in pain research
concerns the mechanisms underlying mechanical sensitivity and
hypersensitivity. Although a number of channels have been
implicated in playing a role in mechanical sensing, there has
been very little definitive evidence for a universal mechanical
transduction mechanism. Members of the TRP channel family
represent reasonable candidates as peripheral sensory mechan-
otransducers [84]. Evidence for mechanosensory properties of
TRP channels ranges from Drosophila to humans channel
studies and from research suggesting a role in hearing in many
species (described above). For example, two TRPV-related
proteins, OSM-9 and OCR-2, have been shown to play
mechanotransduction roles in C. elegans [85,86]. Furthermore,
homologs of the Drosophila TRPN family member nompC
have been found to play a role in the Drosophila mechan-
otransduction and zebrafish hearing [87,88], although no human
homolog for this channel is known to exist [89]. Finally, thetransduction of pain. Many TRP channels thought to be involved in pain are
eral target organs (afferents), such as skin and gastrointestinal tract, as well as
strates a cross-section of the spinal cord, wherein sensory efferents project to the
tion of sensory information to sensory nerve fibers, and also may express TRP
PV1 is expressed in bladder lumen epithelial cells [135]. In the spinal cord, TRP
P channels are also expressed in a variety of immune cells in which they may
found in microglia, which are important cells in the pathogenesis of neuropathic
glia function is unknown.
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to be important in certain aspects of mechanotransduction
associated with touch [90]. Collectively these studies suggest
that the TRP channel superfamily plays a role in mechan-
otransduction and, potentially mechanical nociception or
hypersensitivity in pain-like states.
Yet, evidence to date from mammalian studies is far from
complete. Although the results of some studies suggests a role
of TRPA1 in mechanical nociception, other reports indicate that
this role is not clear and requires further elucidation [43,44,65].
A compelling case can be made for a role of TRPV4 in
mechanical sensing. Studies have observed a mechanical
sensory deficit in both knockout and antisense studies [78,81].
Interestingly, both TRPA1 and TRPV4 have been implicated as
force transducers in auditory hair cells [64,76] although their
role in hearing is debated [91]. Despite the lack of clarity
regarding the role of a number of TRP channels in mechanical
sensory transduction, the data could be indicative of a
remarkable diversity and redundancy in such systems thus
allowing a defect in one mechanosensory mechanism to be
compensated by another. This would certainly allow for subtle
or limited effects of genetic modifications in knockout or
transgenic studies. Furthermore, as signal integrators, certain
physiological stimuli can affect the activation of a channel to
other stimuli. For example, temperature can affect the chemical,
osmotic and mechanical (shear stress) responsiveness of
TRPV4 (the channel is more responsive to these stimuli at
37 °C than at room temperature) and the ligand gating of
TRPA1 [57,92].
In the context of mechanical sensitivity, TRPV1 appears to
be something of an enigma. No study to date has demonstrated
direct mechanical activation of TRPV1. Nonetheless, intriguing
anatomical and physiological evidence implies that TRPV1
may be involved in mechanically-induced responses. Meissner
corpuscles, which are suggested to mediate low threshold
mechanosensitive responses, contain a subset of sensory fibers
that exhibit TRPV1 immunoreactivity. This observation
provides circumstantial evidence that TRPV1-expressing fibers
might be involved in mechanical hypersensitivity [93]. TRPV1
antagonists and TRPV1 antisense oligonucleotide exhibit
efficacy in inflammation and nerve injury-induced mechanical
hypersensitivity [14,51,63]. Additionally, TRPV1 knockout
mice exhibit decreased visceral fiber responses to stretch of the
bladder [94], jejunum [95], and colon [96]. Despite this
supporting evidence, TRPV1−/− mice do not exhibit any
alteration in mechanical hypersensitivity in pain models
[15,42].
5.2. Roles for TRP channels in peripheral and spinal
processing of nociception
Activation of nociceptive pathways can be modified on an
activity-dependent basis, which is manifest as a progressive
increase in response due to repetitive stimuli. This is typically
termed activity-dependent plasticity or sensitization [97].
Generally there are two types of such sensitization that are
relevant to pain systems, namely, autosensitization of noci-ceptor nerve terminals, and sensitization of dorsal horn
neurons and their signaling, often termed “windup”. Both
types of sensitization are relevant for members of the extended
TRP family.
Nociceptor autosensitization has been amply demonstrated
with TRPV1 being at the center due to its integrative properties
as described above. TRPV1 also plays a key role in the
depolarization of nociceptors. The activation of TRPV1
channels results in localized sodium and calcium ion influx,
causing non-propagated neuronal generator potentials [98].
When such generator potentials are sufficiently strong, neuronal
depolarization occurs. This molecular integration coupled with
channel sensitization per se (i.e., by phosphorylation as
described above) would appear to augment its ability to be
intimately associated with and responsible for nociceptive
neuronal transmission in the hyperalgesic state.
Mustard oil has long been used as a selective activator of C-
fibers and sensitizer of dorsal horn neurons [99], and is a
selective activator of TRPA1 channels as discussed above. It is
now appreciated that TRPA1 is coexpressed within a subset of
TRPV1 expressing sensory neurons [100], and as such it
appears that TRPA1 channels play a key role in central
sensitization regarding both thermal and mechanical hypersen-
sitivities. Dorsal horn lamina 1 noci-responsive neurons and
wide dynamic range neurons contain neurokinin-1 receptors,
and mustard oil applied to the relevant receptive field has been
shown to profoundly sensitize the responses of these neurons to
thermal stimulation [101].
Meanwhile, mustard oil does not sensitize the responses of
these lamina I neurons to noxious mechanical stimulation,
demonstrating specificity to the sensitizing effects of mustard
oil in this spinal cord region [101,102]. On the other hand,
spinal cord lamina V neurons play important roles in
mechanical and thermal sensitivity, and receptive field applica-
tion of MO profoundly sensitizes lamina V neurons to
mechanical stimulation in mice [101,103]. A role for TRPA1
in triggering central sensitization is strongly suggested by these
studies. However, TRPA1 knockouts develop a mechanical
hypersensitivity in response to peripheral nerve injury that is
similar to wild-types [44]. Therefore, mechanical hypersensi-
tivity induced by peripheral nerve injury and by mustard oil
application may not be equivalent. The role of TRPA1 in
sensitization requires confirmation using TRPA1 antagonists to
understand its contribution to hypersensitivity in pain models.
Another relevant aspect of nociceptive processing relates to
the profound expression of TRPV1 [53], TRPM8 [104], and
potentially TRPA1 (suggested by its strong DRG expression), in
the sensory neuron projections to the spinal dorsal horn (Fig. 2).
This presynaptic localization suggests the potential for these
TRP channels to be involved in the synaptic release of
neurotransmitters. Indeed, capsaicin is well known to trigger
release of neurotransmitter when directly applied to the spinal
cord [105]. And, menthol increases synaptic transmission in a
DRG-dorsal horn co-culture system [104]. In spite of these data,
very little is known about the function of these channels in pre-
synaptic physiology. Recently, the TRP channel TRPM7 has
been shown to effect acetylcholine release from sympathetic
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physiological synaptic function [106]. Moreover, there is
evidence that central nervous system sites are important in
nociceptive processing. A-795614, a TRPV1 antagonist that
does not penetrate the CNS well, exhibits limited efficacy in
models of pain that exhibit a strong component of central
sensitization. In contrast, A-784168 and other TRPV1 antago-
nists reported in the literature with good CNS exposure, give
good efficacy in those models [107].
With the data at hand, one can conclude that TRPV1 and
TRPA1 play important roles in sensitization as related to
mechanical and thermal pain. These and other TRP channels
may also be involved in the regulation of neurotransmitter
release from spinal efferents to spinal dorsal horn neurons (Fig.
2). It will be important to understand the extent to which these
and other TRP channel members affect nociceptive processing,
particularly given the importance of central sensitization in
chronic pain.
5.3. Potential role for TRP channels in inflammation:
Implications for pain
Research on TRP channels and pain has largely been focused
on aspects of nociceptive processing. However, sensory
neurons are also implicated in neurogenic inflammation, a
process in which neuropeptides, such as substance P and CGRP,
are released from the peripheral termini of sensory fibers
resulting in peripheral vasodilation, vascular leak, and effects on
immune cells. These responses are thought to contribute to
certain disorders including migraine, in which CGRP released
from trigeminal ganglion peripheral nerve endings mediates a
vasodilatory, pro-algesic effect [108]. Since capsaicin has been
widely used to trigger experimental neurogenic inflammation,
TRPV1 is implicated as an important player in that process [18].
Indeed, capsazepine significantly inhibits the development of
inflammation in an enteritis model [109].
The effect of sensory fiber activation on inflammation,
however, is a two-way street. Inflammatory processes generate
molecules, such as the pro-inflammatory cytokine, TNFalpha,
that are released from activated macrophages, mast cells, and
other immune cells, and which have direct and indirect effects
on nociceptors [110]. An important characteristic of some
immune cell types, including T lymphocytes and mast cells, is
the presence of receptor activated calcium mobilization. This
can be mediated by inositol 1,4,5-trisphosphate (IP3)-activated
receptors and non-IP3-activated receptors as well as store-
operated calcium currents (SOC) or calcium release-activated
calcium current (CRAC). These currents are thought to play a
pivotal role in the functional outcome of cell activation, such as
degranulation, reactive oxygen generation, or proliferation
[111]. It has been appreciated for some time that TRP channels,
particularly TRPC subfamily members, are sensitive to the
intracellular signaling molecule diacylglycerol [112], placing
TRP channels in the pathway connecting activation of
phospholipase (by, for example, G protein coupled receptor
engagement) can mediate calcium mobilization and/or influx.
Numerous investigations have also suggested a connectionbetween SOC and CRAC currents and TRP channels [113].
Recent data suggest that other proteins (STIM1 and CRACM1)
may be necessary and sufficient to mediate CRAC [114], but
TRP channels may interact with these proteins in some cases to
mediate SOC currents [115].
One example of the connection between TRP channels and
receptor-activated currents is TRPC3, which is activated by B
cell receptor in an avian B cell line [116], and T cell receptor in
human Jurkat T cells [117]. Another example is TRPV6, which
exhibits properties of calcium release-activated current in Jurkat
T cells [118]. Since receptor-activated calcium currents are
important for T cell activation [119], it is tempting to speculate
that TRPC3, TRPV6, and other TRP channels are involved in T
cell events that might result in the release of factors, such as
TNFalpha, that mediate pain.
TRPV2 is the target of protein kinase A phosphorylation-
dependent mast cell surface expression, and contributes to
functional mast cell degranulation [120]. However, TRPV1 is
also expressed in mast cells [121], raising the possibility that,
like in sensory neurons, TRPV1 sensitization may mediate
activation of these cells. The release of histamine, serotonin,
and proteases from mast cells may contribute to hyperalgesia
via increased local blood flow or edema and through direct
actions on nociceptors.
Two members of the TRPM family have potential roles in
immune cell activation. TRPM2 is expressed in granulocytes
[122] and lymphocytes [123], among other cell types. It is
activated by NAD such that increased H2O2 levels, generated
during oxidative burst in granulocytes, mediates calcium influx
via nicotinamide adenine dinucleotide (NAD) activation of
TRPM2 [122,124]. Adenosine diphosphoribose (ADPR) is also
an activator of TRPM2. Increased intracellular ADPR levels
observed in Jurkat T cells after concanavalin A treatment activate
TRPM2 [123], suggesting a role for this channel in T cell
activation. TRPM4 has also been implicated in T cell activation
events by regulating intracellular calcium levels. Inhibition of
TRPM4 function results in increased phytohemagglutinin (PHA)-
induced IL-2 secretion [125], while facilitation of TRPM4
currents decreases PHA IL-2 release [126].
It is clear that many TRP channels are expressed in immuno-
cytes, including lymphocytes, neutrophils, macrophages, mast
cells, and glia [127–130], but, with some intriguing exceptions
(noted above), the functional roles of TRP channels in immune
cells are unclear. In addition, multiple TRP channels can be
found functionally expressed in the same cell type; for example,
TRPC3, TRPV6, and TRPM2 expression in T cells as described
above. The ways in which multiple TRP channels indepen-
dently or in concert effect immune cell function remain to be
elucidated.
6. Conclusions
In the almost 20 years since their discovery, TRP channels
have been implicated in a broad range of physiological activities.
The identification of the receptor for capsaicin in 1997 as a TRP
channel [15] heralded a new era in the molecular understanding
of pain sensation. Today, we appreciate that at least 6
985D.N. Cortright et al. / Biochimica et Biophysica Acta 1772 (2007) 978–988temperature-sensitive TRP channels are expressed in sensory
neurons, and most of these are also receptors for sensory-active
substances such as menthol, mustard oil, and venoms.
Pharmacological inhibitors and genetic knockout and knock-
down strategies demonstrate that inhibition of these TRP
channels may be effective therapeutic strategies for pain.
Emerging data implicate TRP channels in sensing mechanical
stimuli, in spinal neurotransmitter release, and in immune cell
function, all of which underscore the potential importance of
TRP channels as targets for the next generation of pain therapies.
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